Using CRISPR/Cas9, scientists identified RBM5 as a vital component of leukemia cell fitness, making it a promising target for drug development.
Home Science HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid...
HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia
